First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model

Martine Dubois; Benjamin Quignon; Marie-Christine Tonon; Pierrick Gandolfo; Florence Joly; Hélène Castel

Conference Papers Year :

First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model

(1) , (1) , (1) , (1) , (2) , (1)

1
2

Martine Dubois

Function : Author

Différenciation et communication neuronale et neuroendocrine

Benjamin Quignon

Function : Author

Différenciation et communication neuronale et neuroendocrine

Marie-Christine Tonon

Function : Author

Différenciation et communication neuronale et neuroendocrine

Pierrick Gandolfo

Function : Author

Différenciation et communication neuronale et neuroendocrine

Florence Joly

Function : Author
PersonId : 1015787

Service d'Oncologie médicale [CHU Caen]

Hélène Castel

Function : Author
PersonId : 181762
IdHAL : helene-castel
ORCID : 0000-0002-8972-5555
IdRef : 081904487

Différenciation et communication neuronale et neuroendocrine

Domains

Cognitive science Life Sciences [q-bio] Cancer

Hélène CASTEL : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-02299483

Submitted on : Friday, September 27, 2019-5:34:42 PM

Last modification on : Tuesday, October 19, 2021-4:15:43 PM

Dates and versions

hal-02299483 , version 1 (27-09-2019)

Identifiers

HAL Id : hal-02299483 , version 1

Cite

Martine Dubois, Benjamin Quignon, Marie-Christine Tonon, Pierrick Gandolfo, Florence Joly, et al.. First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model. World Congress on Neurotherapeutics (DDDN), Sep 2014, Bâle, Switzerland. ⟨hal-02299483⟩

First "chemofog" syndrome reported for cancer anti-angiogenic targeted therapy in a preclinical model

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share